• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med Microbiol Immunol . Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19

tetano

Editor, Senior Moderator
Med Microbiol Immunol


. 2022 Jan 13.
doi: 10.1007/s00430-021-00727-0. Online ahead of print.
Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19


Shuangyan Li[SUP] #[/SUP][SUP] 1 [/SUP], Fuxiaonan Zhao[SUP] #[/SUP][SUP] 1 [/SUP], Jing Ye[SUP] #[/SUP][SUP] 1 [/SUP], Kuan Li[SUP] #[/SUP][SUP] 1 2 [/SUP], Qi Wang[SUP] 1 2 [/SUP], Zhongchao Du[SUP] 1 2 [/SUP], Qing Yue[SUP] 1 [/SUP], Sisi Wang[SUP] 1 [/SUP], Qi Wu[SUP] 3 4 [/SUP], Huaiyong Chen[SUP] 5 6 7 8 [/SUP]



Affiliations

Abstract

Metabolic pathways drive cellular behavior. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lung tissue damage directly by targeting cells or indirectly by producing inflammatory cytokines. However, whether functional alterations are related to metabolic changes in lung cells after SARS-CoV-2 infection remains unknown. Here, we analyzed the lung single-nucleus RNA-sequencing (snRNA-seq) data of several deceased COVID-19 patients and focused on changes in transcripts associated with cellular metabolism. We observed upregulated glycolysis and oxidative phosphorylation in alveolar type 2 progenitor cells, which may block alveolar epithelial differentiation and surfactant secretion. Elevated inositol phosphate metabolism in airway progenitor cells may promote neutrophil infiltration and damage the lung barrier. Further, multiple metabolic alterations in the airway goblet cells are associated with impaired muco-ciliary clearance. Increased glycolysis, oxidative phosphorylation, and inositol phosphate metabolism not only enhance macrophage activation but also contribute to SARS-CoV-2 induced lung injury. The cytotoxicity of natural killer cells and CD8[SUP]+[/SUP] T cells may be enhanced by glycerolipid and inositol phosphate metabolism. Glycolytic activation in fibroblasts is related to myofibroblast differentiation and fibrogenesis. Glycolysis, oxidative phosphorylation, and glutathione metabolism may also boost the aging, apoptosis and proliferation of vascular smooth muscle cells, resulting in pulmonary arterial hypertension. In conclusion, this preliminary study revealed a possible cellular metabolic basis for the altered innate immunity, adaptive immunity, and niche cell function in the lung after SARS-CoV-2 infection. Therefore, patients with COVID-19 may benefit from therapeutic strategies targeting cellular metabolism in future.

Keywords: COVID-19; Cellular metabolism; Glycolysis; Host immunity; RNA sequencing.
 
Back
Top Bottom